Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obutinib or Decitabine with R-CP in Elderly DLBCL
NCT06683885Phase 2Recruiting
- Start
- Nov 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of orelabrutinib, decitabine in diffuse large B-cell lymphoma (DLBCL). Started Nov 2024; status: recruiting.
02
Drugs
orelabrutinibdecitabine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06683885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06683885.